{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:23:39Z","timestamp":1792801419677,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T00:00:00Z","timestamp":1554940800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12955-019-1125-x","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T14:04:24Z","timestamp":1554991464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A systematic literature review of patient-reported outcome measures used in gout: an evaluation of their content and measurement properties"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6359-916X","authenticated-orcid":false,"given":"Carly A.","family":"Janssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn A. H.","family":"Oude Voshaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"ten Klooster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim L. Th. A.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald E.","family":"Vonkeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart A. F. J.","family":"van de Laar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,11]]},"reference":[{"key":"1125_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0140-6736(09)60883-7","volume":"375","author":"P Richette","year":"2010","unstructured":"Richette P, Bardin T. Gout. Lancet. 2010;375:318\u201328.","journal-title":"Lancet."},{"key":"1125_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3111\/13696998.2010.540874","volume":"14","author":"NL Edwards","year":"2011","unstructured":"Edwards NL, Sundy JS, Forsythe A, Blume S, Pan F, Becker MA. Work productivity loss due to flares in patients with chronic gout refractory to conventional therapy. J Med Econ. 2011;14:10\u20135.","journal-title":"J Med Econ"},{"key":"1125_CR3","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3899\/jrheum.071229","volume":"36","author":"MA Becker","year":"2009","unstructured":"Becker MA, Schumacher HR, Benjamin KL, Gorevic P, Greenwald M, Fessel J, et al. Quality of life and disability in patients with treatment-failure gout. J Rheumatol. 2009;36:1041\u20138.","journal-title":"J Rheumatol"},{"key":"1125_CR4","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/ar4159","volume":"15","author":"RA Terkeltaub","year":"2013","unstructured":"Terkeltaub RA, Schumacher HR, Carter JD, Baraf HSB, Evans RR, Wang J, et al. Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator. Arthritis Res Ther BioMed Central Ltd. 2013;15:R25.","journal-title":"Arthritis Res Ther"},{"key":"1125_CR5","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/rheumatology\/ket265","volume":"52","author":"P Chandratre","year":"2013","unstructured":"Chandratre P, Roddy E, Clarson L, Richardson J, Hider SL, Mallen CD. Health-related quality of life in gout: a systematic review. Rheumatology. 2013;52:2031\u201340.","journal-title":"Rheumatology."},{"key":"1125_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11136-009-9451-9","volume":"18","author":"LB Mokkink","year":"2009","unstructured":"Mokkink LB, Terwee CB, Stratford PW, Alonso J, Patrick DL, Riphagen I, et al. Evaluation of the methodological quality of systematic reviews of health status measurement instruments. Qual Life Res. 2009;18:313\u201333.","journal-title":"Qual Life Res"},{"key":"1125_CR7","first-page":"2452","volume":"32","author":"HR Schumacher","year":"2005","unstructured":"Schumacher HR, Edwards LN, Perez-Ruiz F, Becker M, Chen LX, Furst DE, et al. Outcome measures for acute and chronic gout. J Rheumatol. 2005;32:2452\u20135.","journal-title":"J Rheumatol"},{"key":"1125_CR8","first-page":"1381","volume":"34","author":"HR Schumacher","year":"2007","unstructured":"Schumacher HR, Taylor W, Joseph-Ridge N, Perez-Ruiz F, Chen LX, Schlesinger N, et al. Outcome evaluations in gout. J Rheumatol. 2007;34:1381\u20135.","journal-title":"J Rheumatol"},{"key":"1125_CR9","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1136\/ard.2007.079970","volume":"67","author":"WJ Taylor","year":"2008","unstructured":"Taylor WJ, Schumacher HR Jr, Baraf HSB, Chapman P, Stamp L, Doherty M, et al. A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout. Ann Rheum Dis. 2008;67:888\u201391.","journal-title":"Ann Rheum Dis"},{"key":"1125_CR10","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.3899\/jrheum.090370","volume":"36","author":"HR Schumacher","year":"2009","unstructured":"Schumacher HR, Taylor W, Edwards L, Grainger R, Schlesinger N, Dalbeth N, et al. Outcome domains for studies of acute and chronic gout. J Rheumatol. 2009;36:2342\u20135.","journal-title":"J Rheumatol"},{"key":"1125_CR11","first-page":"198","volume":"25","author":"M Boers","year":"1998","unstructured":"Boers M, Brooks P, Strand CV, Tugwell P. The OMERACT filter for outcome measures in rheumatology. J Rheumatol. 1998;25:198\u20139.","journal-title":"J Rheumatol"},{"key":"1125_CR12","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.3899\/jrheum.090371","volume":"36","author":"R Grainger","year":"2009","unstructured":"Grainger R, Taylor WJ, Dalbeth N, Perez-Ruiz F, Singh JA, Waltrip RW, et al. Progress in measurement instruments for acute and chronic gout studies. J Rheumatol. 2009;36:2346\u201355.","journal-title":"J Rheumatol"},{"key":"1125_CR13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3899\/jrheum.131246","volume":"41","author":"JA Singh","year":"2014","unstructured":"Singh JA, Taylor WJ, Dalbeth N, Simon LS, Sundy J, Grainger R, et al. OMERACT endorsement of measures of outcome for studies of acute gout. J Rheumatol. 2014;41:569\u201373.","journal-title":"J Rheumatol"},{"key":"1125_CR14","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3899\/jrheum.131244","volume":"41","author":"N Dalbeth","year":"2014","unstructured":"Dalbeth N, Zhong CS, Grainger R, Khanna D, Khanna PP, Singh JA, et al. Outcome measures in acute gout: a systematic literature review. J Rheumatol. 2014;41:558\u201368.","journal-title":"J Rheumatol"},{"key":"1125_CR15","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3899\/jrheum.131245","volume":"41","author":"WJ Taylor","year":"2014","unstructured":"Taylor WJ, Redden D, Dalbeth N, Schumacher HR, Edwards NL, Simon LS, et al. Application of the OMERACT filter to measures of core outcome domains in recent clinical studies of acute gout. J Rheumatol. 2014;41:574\u201380.","journal-title":"J Rheumatol"},{"key":"1125_CR16","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1093\/rheumatology\/kem178","volume":"46","author":"WJ Taylor","year":"2007","unstructured":"Taylor WJ, Schumacher HR, Singh JA, Grainger R, Dalbeth N. Assessment of outcome in clinical trials of gout--a review of current measures. Rheumatology (Oxford). 2007;46:1751\u20136.","journal-title":"Rheumatology (Oxford)"},{"key":"1125_CR17","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.3899\/jrheum.110271","volume":"38","author":"JA Singh","year":"2011","unstructured":"Singh JA, Taylor WJ, Simon LS, Khanna PP, Stamp LK, McQueen FM, et al. Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol. 2011;38:1452\u20137.","journal-title":"J Rheumatol"},{"key":"1125_CR18","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s11136-009-9528-5","volume":"18","author":"CB Terwee","year":"2009","unstructured":"Terwee CB, Jansma EP, Riphagen II, De Vet HCW. Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments. Qual Life Res. 2009;18:1115\u201323.","journal-title":"Qual Life Res"},{"key":"1125_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman D, The PRISMA group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PloS Med. 2009;6:e1000097.","journal-title":"PloS Med"},{"key":"1125_CR20","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s11136-012-0344-y","volume":"22","author":"BB Reeve","year":"2013","unstructured":"Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, et al. ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research. Qual Life Res. 2013;22:1889\u2013905.","journal-title":"Qual Life Res"},{"key":"1125_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11136-010-9606-8","volume":"19","author":"LB Mokkink","year":"2010","unstructured":"Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res. 2010;19:539\u201349.","journal-title":"Qual Life Res"},{"key":"1125_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1471-2288-11-152","volume":"11","author":"F Angst","year":"2011","unstructured":"Angst F. The new COSMIN guidelines confront traditional concepts of responsiveness. BMC Med Res Methodol. 2011;11:152.","journal-title":"BMC Med Res Methodol"},{"key":"1125_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11336-008-9101-0","volume":"74","author":"K Sijtsma","year":"2009","unstructured":"Sijtsma K. On the use, the misuse, and the very limited usefulness of cronbach\u2019s alpha. Psychometrika. 2009;74:107\u201320.","journal-title":"Psychometrika."},{"key":"1125_CR24","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1177\/0146621610392911","volume":"35","author":"LA Ark van der","year":"2011","unstructured":"van der Ark LA, van der Palm DW, Sijtsma K. A latent class approach to estimating test-score reliability. Appl Psychol Meas. 2011;35:380\u201392.","journal-title":"Appl Psychol Meas"},{"key":"1125_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","volume":"61","author":"D Revicki","year":"2008","unstructured":"Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61:102\u20139.","journal-title":"J Clin Epidemiol"},{"key":"1125_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","volume":"60","author":"CB Terwee","year":"2007","unstructured":"Terwee CB, Bot SDM, de Boer MR, van der Windt DAWM, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34\u201342.","journal-title":"J Clin Epidemiol"},{"key":"1125_CR27","doi-asserted-by":"crossref","unstructured":"Cieza A, Fayed N, Bickenbach J, Prodinger B. Refinements of the ICF linking rules to strengthen their potential for establishing comparability of health information. Disabil Rehabil. 2016:1\u201310.","DOI":"10.3109\/09638288.2016.1145258"},{"key":"1125_CR28","first-page":"252","volume":"25","author":"E Grill","year":"2007","unstructured":"Grill E, Zochling J, Stucki G, Mittrach R, Scheuringer M, Liman W, et al. International classification of functioning, disability and health (ICF) Core set for patients with acute arthritis. Clin Exp Rheumatol. 2007;25:252\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"1125_CR29","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s10067-016-3325-7","volume":"35","author":"EM Kool","year":"2016","unstructured":"Kool EM, Nijsten MJ, van Ede AE, Jansen TL, Taylor WJ. Discrepancies in how the impact of gout is assessed in outcomes research compared to how health professionals view the impact of gout, using the lens of the international classification of functioning, health and disability (ICF). Clin Rheumatol. 2016;35:2259\u201368.","journal-title":"Clin Rheumatol"},{"key":"1125_CR30","unstructured":"Hambleton RK, Swaminathan H, Rogers HJ. Fundamentals of item response theory. Newbury Park, California: sage publications, Inc.; 1991."},{"key":"1125_CR31","first-page":"114","volume":"1","author":"S Choi","year":"1997","unstructured":"Choi S, Cook K, Dodd B. Parameter recovery for the partial credit model using MULTILOG. J Outcome Meas. 1997;1:114\u201342.","journal-title":"J Outcome Meas"},{"key":"1125_CR32","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s10067-013-2400-6","volume":"33","author":"PM Klooster Ten","year":"2014","unstructured":"Ten Klooster PM, Vonkeman HE, Oude Voshaar MAH, Bode C, Van De Laar MAFJ. Experiences of gout-related disability from the patients\u2019 perspective: a mixed methods study. Clin Rheumatol. 2014;33:1145\u201354.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1125_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S2173-5743(09)70101-7","volume":"5","author":"Everardo \u00c1lvarez-Hern\u00e1ndez","year":"2009","unstructured":"\u00c1lvarez-Hern\u00e1ndez E, Zamudio-Lerma JA, Burgos-Mart\u00ednez G, \u00c1lvarez-Etchegaray SE, Pel\u00e1ez-Ballestas I, V\u00e1zquez-Mellado J. [Measurement of health-related quality of life and functional capacity in patients with chronic tophaceous gout]. Reumatol Clin Elsevier; 2009;5:103\u2013108.","journal-title":"Reumatolog\u00eda Cl\u00ednica (English Edition)"},{"key":"1125_CR34","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.3899\/jrheum.080506","volume":"35","author":"JD Hirsch","year":"2008","unstructured":"Hirsch JD, Lee SJ, Terkeltaub R, Khanna D, Singh JA, Sarkin A, et al. Evaluation of an instrument assessing influence of gout on health-related quality of life. J Rheumatol. 2008;35:2406\u201314.","journal-title":"J Rheumatol"},{"key":"1125_CR35","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1136\/ard.2010.144022","volume":"70","author":"JA Singh","year":"2011","unstructured":"Singh JA, Yang S, Strand V, Simon L, Forsythe A, Hamburger S, et al. Validation of pain and patient global scales in chronic gout: data from two randomised controlled trials. Ann Rheum Dis. 2011;70:1277\u201381.","journal-title":"Ann Rheum Dis"},{"key":"1125_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/RHU.0b013e3182779805","volume":"18","author":"WJ Taylor","year":"2012","unstructured":"Taylor WJ, House M, Horne A, McQueen FM, Dalbeth N. The work instability scale predicts absenteeism in people with gout and suggests a higher risk for those in manual occupations. J Clin Rheumatol. 2012;18:405\u201310.","journal-title":"J Clin Rheumatol"},{"key":"1125_CR37","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/rheumatology\/keq387","volume":"50","author":"PM Klooster ten","year":"2011","unstructured":"ten Klooster PM, Oude Voshaar MAH, Taal E, van de Laar MAFJ. Comparison of measures of functional disability in patients with gout. Rheumatology. 2011;50:709\u201313.","journal-title":"Rheumatology."},{"key":"1125_CR38","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s11136-010-9690-9","volume":"19","author":"MM Groen Van","year":"2010","unstructured":"Van Groen MM, Ten Klooster PM, Taal E, Van De Laar MAFJ, Glas CAW. Application of the health assessment questionnaire disability index to various rheumatic diseases. Qual Life Res. 2010;19:1255\u201363.","journal-title":"Qual Life Res"},{"key":"1125_CR39","first-page":"620","volume":"26","author":"WJ Taylor","year":"2008","unstructured":"Taylor WJ, Colvine K, Gregory K, Collis J, McQueen FM, Dalbeth N. The health assessment questionnaire disability index is a valid measure of physical function in gout. Clin Exp Rheumatol. 2008;26:620\u20136.","journal-title":"Clin Exp Rheumatol"},{"key":"1125_CR40","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/art.23575","volume":"59","author":"E \u00c1lvarez-Hern\u00e1ndez","year":"2008","unstructured":"\u00c1lvarez-Hern\u00e1ndez E, Pel\u00e1ez-Ballestas I, V\u00e1zquez-Mellado J, Ter\u00e1n-Estrada L, Bernard-Medina AG, Espinoza J, et al. Validation of the health assessment questionnaire disability index in patients with gout. Arthritis Rheum. 2008;59:665\u20139.","journal-title":"Arthritis Rheum"},{"key":"1125_CR41","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1093\/rheumatology\/kew007","volume":"55","author":"B Wallace","year":"2016","unstructured":"Wallace B, Khanna D, Aquino-Beaton C, Singh JA, Duffy E, Elashoff D, et al. Performance of gout impact scale in a longitudinal observational study of patients with gout. Rheumatology. 2016;55:982\u201390.","journal-title":"Rheumatology."},{"key":"1125_CR42","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1136\/annrheumdis-2014-205671","volume":"74","author":"O Aati","year":"2015","unstructured":"Aati O, Taylor WJ, Siegert RJ, Horne A, House ME, Tan P, et al. Development of a patient-reported outcome measure of tophus burden: the tophus impact questionnaire (TIQ-20). Ann Rheum Dis. 2015;74:2144\u201350.","journal-title":"Ann Rheum Dis"},{"key":"1125_CR43","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/rheumatology\/ket423","volume":"53","author":"B Spaetgens","year":"2014","unstructured":"Spaetgens B, Van der linden S, Boonen A. The gout assessment questionnaire 2.0: cross-cultural translation into dutch, aspects of validity and linking to the international classification of functioning, disability and health. Rheumatology. 2014;53:678\u201385.","journal-title":"Rheumatology."},{"key":"1125_CR44","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/rheumatology\/keq346","volume":"50","author":"PP Khanna","year":"2011","unstructured":"Khanna PP, Perez-Ruiz F, Maranian P, Khanna D. Long-term therapy for chronic gout results in clinically important improvements in the health-related quality of life: short form-36 is responsive to change in chronic gout. Rheumatology. 2011;50:740\u20135.","journal-title":"Rheumatology."},{"key":"1125_CR45","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","volume":"63","author":"D Cella","year":"2010","unstructured":"Cella D, Riley W, Stone A, Rothrock N, Reeve B, Yount S, et al. The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol Elsevier Inc. 2010;63:1179\u201394.","journal-title":"J Clin Epidemiol Elsevier Inc"},{"key":"1125_CR46","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/ar3297","volume":"13","author":"N Schlesinger","year":"2011","unstructured":"Schlesinger N, De Meulemeester M, Pikhlak A, Y\u00fccel AE, Richard D, Murphy V, et al. Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat gouty arthritis by suppressing inflammation: results of a randomized, dose-ranging study. Arthritis Res Ther. 2011;13:R53.","journal-title":"Arthritis Res Ther."},{"key":"1125_CR47","doi-asserted-by":"publisher","first-page":"810","DOI":"10.12659\/MSM.895749","volume":"22","author":"L Xu","year":"2016","unstructured":"Xu L, Liu S, Guan M, Xue Y. Comparison of prednisolone, Etoricoxib, and indomethacin in treatment of acute gouty arthritis: an open-label, randomized, controlled trial. Med Sci Monit. 2016;22:810\u20137.","journal-title":"Med Sci Monit"},{"key":"1125_CR48","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/acr.21690","volume":"64","author":"HR Schumacher","year":"2012","unstructured":"Schumacher HR, Evans RR, Saag KG, Clower J, Jennings W, Weinstein SP, et al. Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study. Arthritis Care Res. 2012;64:1462\u201370.","journal-title":"Arthritis Care Res"},{"key":"1125_CR49","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1002\/art.40159","volume":"69","author":"N Dalbeth","year":"2017","unstructured":"Dalbeth N, Jones G, Terkeltaub R, Khanna D, Kopicko J, Bhakta N, et al. Lesinurad, a selective uric acid reabsorption inhibitor, in combination with Febuxostat in patients with Tophaceous gout: findings of a phase III clinical trial. Arthritis Rheumatol. 2017;69:1903\u201313.","journal-title":"Arthritis Rheumatol"},{"key":"1125_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.clinpsy.032408.153639","volume":"5","author":"ME Strauss","year":"2009","unstructured":"Strauss ME, Smith GT. Construct validity: advances in theory and methodology. Annu Rev Clin Psychol. 2009;5:1\u201325.","journal-title":"Annu Rev Clin Psychol"},{"key":"1125_CR51","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/ard.2006.059451","volume":"66","author":"M Boers","year":"2007","unstructured":"Boers M, Jacobs JWG, van Vliet Vlieland TPM, van Riel PLCM. Consensus Dutch health assessment questionnaire. Ann Rheum Dis. 2007;66:132\u20133.","journal-title":"Ann Rheum Dis"},{"key":"1125_CR52","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"M Reilly","year":"1993","unstructured":"Reilly M, Zbrozek A, Dukes E. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353\u201365.","journal-title":"Pharmacoeconomics."}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-019-1125-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12955-019-1125-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-019-1125-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T23:25:58Z","timestamp":1586474758000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-019-1125-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,11]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1186\/s12955-019-1125-x","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,11]]},"assertion":[{"value":"8 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"63"}}